Basic Information
| LncRNA/CircRNA Name | LINC00202 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | retinoblastoma |
| ICD-0-3 | C69.2 |
| Methods | qPCR, Luciferase reporter assay |
| Sample | RB tissues |
| Expression Pattern | up-regulated |
| Function Description | LINC00202 expression in RB tissues is higher than that in the paired adjacent normal tissues, which has correlation with poor prognosis in RB. |
| Pubmed ID | 30905893 |
| Year | 2019 |
| Title | Long Noncoding RNA LINC00202 Promotes Tumor Progression by Sponging miR -3619-5p in Retinoblastoma. |
External Links
| Links for LINC00202 | GenBank HGNC NONCODE |
| Links for retinoblastoma | OMIM COSMIC |